Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Apomorphine for 'Off' Episodes in Parkinson's Disease
NCT00142545Phase 3Completed
- Sponsor
- Viatris
- Start
- Jul 1999
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of apomorphine in Parkinson's disease (PD), sponsored by Viatris. Primary endpoints: Adverse Events, Clinical laboratory tests and 3 more. Started Jul 1999; status: completed.
02
Drugs
apomorphine
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT00142545.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00142545.